Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response. [PDF]
Hyperphagia is a hallmark of both congenital and acquired rare melanocortin-4 receptor (MC4R) pathway diseases. Currently, the medical community has no standard treatment guidelines or approach to establishing treatment benefit.
Argente J +7 more
europepmc +3 more sources
Natural History of Hyperphagia in Patients with Pseudohypoparathyroidism. [PDF]
Background/Objectives: Pseudohypoparathyroidism (PHP) is a group of genetic disorders characterized by end-organ resistance to multiple hormones, short stature, brachydactyly, subcutaneous ossifications, obesity, and developmental delays.
Tamaroff J, Shoemaker AH.
europepmc +2 more sources
Barriers, Limitations, and Experiences with Clinical Trials-Treatment in Rare Diseases with Prader-Willi Syndrome as an Example. [PDF]
Butler MG, Silvey S, van Bosse HJP.
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Brittain HR, Gorvin CM.
europepmc +1 more source
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome. [PDF]
Revana A +11 more
europepmc +1 more source
Treatment Priorities in Craniopharyngioma: Perspectives of Survivors and Caregivers. [PDF]
Kayadjanian N, Hsu EA.
europepmc +1 more source
Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice. [PDF]
Keller C +5 more
europepmc +1 more source
Central nervous system adaptation mechanism of obesity induced by high-fat high-sucrose diet: Differences in brain function between obese and obese resistant rats based on fMRI. [PDF]
Fang Q +7 more
europepmc +1 more source
Case Report: Schaaf-Yang Syndrome Milder Phenotype Due to Potential Pathogenic Novel Missense Variant as an Unusual Cause of Obesity in a Pediatric Patient. [PDF]
Pastucha D +6 more
europepmc +1 more source
Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts.
Tan Q +14 more
europepmc +1 more source

